STAT

This brand-new advocacy group is an unapologetic defender of high drug prices

It’s not clear who funds this new advocacy group or when it officially launched, but it’s already clear which side of the drug pricing debate it’s on.

WASHINGTON — It’s less than a week old, but a shadowy new pharma advocacy group is already launching diatribes against advocates for lower drug prices, blasting pharmacy middlemen and defending even sky-high list prices for prescription drugs.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
Purdue Pharma, Maker Of OxyContin And Other Drugs, Files For Bankruptcy
Facing thousands of lawsuits alleging that it helped spark the opioid addiction crisis, privately held Purdue Pharma announced it had filed for bankruptcy,
STAT4 min read
An FDA Advisory Panel Is Reviewing Aimmune’s Peanut Allergy Therapy. Here’s What’s Happening
STAT's @adamfeuerstein will be watching watching a live feed of today’s FDA advisory panel to discuss a peanut allergy treatment. Follow along for updates.
STAT3 min readSociety
Opinion: A Dangerous View: Why It’s A Mistake For Medical Schools To Ignore Social Justice
An op-ed in the Wall Street Journal called for getting back to basics in medical school and forgoing teaching on gun violence or other social issues. The author has it…